Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.
about
Molecular mechanisms of chromium in alleviating insulin resistanceTrace elements in glucometabolic disorders: an update.Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) studyEvaluation of the acute oral toxicity class of trinuclear chromium(III) glycinate complex in ratEpigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants.Glutathione homeostasis and functions: potential targets for medical interventionsEfficacy of zinc oxide nanoparticles in attenuating pancreatic damage in a rat model of streptozotocin-induced diabetes.Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus.Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial.Antidiabetic activity of zinc oxide and silver nanoparticles on streptozotocin-induced diabetic rats.Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE-/- mice.Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control StudyMetal-based anti-diabetic drugs: advances and challenges.Heavy metal in the intensive care unit: a review of current literature on trace element supplementation in critically ill patients.Nutrients other than carbohydrates: their effects on glucose homeostasis in humans.Serum Trace Elements and Electrolytes Are Associated with Fasting Plasma Glucose and HbA1c in Postmenopausal Women with Type 2 Diabetes Mellitus.Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities.Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome.Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes.Trivalent chromium inhibits TSP-1 expression, proliferation, and O-GlcNAc signaling in vascular smooth muscle cells in response to high glucose in vitro.High frequency of serum chromium deficiency and association of chromium with triglyceride and cholesterol concentrations in patients awaiting bariatric surgery.Chromium Supplementation Reduces Resting Heart Rate in Patients with Metabolic Syndrome and Impaired Glucose Tolerance.Green Synthesis of Oxovanadium(IV)/chitosan Nanocomposites and Its Ameliorative Effect on Hyperglycemia, Insulin Resistance, and Oxidative Stress.In vitro studies on the pleotropic antidiabetic effects of zinc oxide nanoparticles.Biosynthesis of Cr(III) nanoparticles from electroplating wastewater using chromium-resistant Bacillus subtilis and its cytotoxicity and antibacterial activity.
P2860
Q28262068-A392C3E7-9A3D-4D4E-B85C-E0869582EB67Q34504189-5D0D8FDE-1D3C-4BB5-AD96-7FA7D7DAB697Q35122357-C1370D07-2400-4CC2-ACEA-63B963143F93Q35174979-327C7A5B-2B1A-404D-86E1-2AB951E02A7DQ35566538-E6FCEB39-65D4-442D-894A-C8F05F58283BQ35697918-E65B4D74-2183-4A36-ABCD-9DD16683C87EQ35829968-7754A62E-BB13-4F59-84EE-B61BB7D177EFQ36202355-84070E73-1CBC-4175-A879-2BCC7CBA8EC0Q37349590-0694CAE1-2D89-44FA-ACA5-5FD61910C99DQ37470658-05BE8F19-CABE-47A9-BD4D-2247517878D3Q37615433-ECE64AC8-6A4C-472A-84AC-7EC74FA23824Q37645135-CDF701C0-FA09-4A07-9C94-D0F11E747E79Q37721606-FA0116C3-DAE8-4E00-9977-77877016EB03Q37729865-0CBE7DBB-BAFA-4C28-B77A-1AAE2BA7283BQ37900507-750641EE-7EE2-4799-BFF4-607FA1465564Q38171238-912C1180-F5B3-44BF-9ABB-39EAAA505D99Q38186619-D6579090-33F3-464B-B827-53B929615454Q39279059-6A2A5882-1642-4C58-8384-06AC746A973CQ39623410-CFFA63DE-A321-4913-A14B-9095897CCE09Q42417679-478869E9-6601-4E30-80B7-47734EC5ED26Q42519392-33511BB8-82F3-4918-9DFB-E8845AC6A798Q42721900-00D60438-E966-4A3B-906B-F445FA7B838EQ46820224-309FAFD0-5218-4AC3-BF1A-62CD852E35FFQ46947353-D6E8D00A-6A66-4F21-8E9A-13D8CC79BB9DQ47284040-EED4971A-347E-4C78-B232-157680D1F62EQ50262063-8FFFF415-A5F8-4817-93EA-0679173FCB9AQ51678237-6B240885-A8D0-4902-B231-679DBC01E8C0Q52849990-ACF77056-9311-4B1A-BDAF-1080F4964B4E
P2860
Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current concepts about chromiu ...... abetes and insulin resistance.
@en
Current concepts about chromiu ...... abetes and insulin resistance.
@nl
type
label
Current concepts about chromiu ...... abetes and insulin resistance.
@en
Current concepts about chromiu ...... abetes and insulin resistance.
@nl
prefLabel
Current concepts about chromiu ...... abetes and insulin resistance.
@en
Current concepts about chromiu ...... abetes and insulin resistance.
@nl
P2860
P1476
Current concepts about chromiu ...... abetes and insulin resistance.
@en
P2093
Zhong Q Wang
P2860
P2888
P304
P356
10.1007/S11892-010-0097-3
P577
2010-04-01T00:00:00Z